Education
About Us
Working with TipRanks
Follow Us
FLSW - ETF AI Analysis
Top Page
Franklin FTSE Switzerland ETF (FLSW)
Rating:70Neutral
Price Target:―
Positive Factors
Strong Top Holdings
Several key holdings, including Nestlé, Roche, and Novartis, have shown strong year-to-date performance, supporting the ETF's overall returns.
Low Expense Ratio
The ETF has a very low expense ratio, making it cost-effective for investors compared to similar funds.
Health Care Focus
With significant exposure to the health care sector, the ETF benefits from the stability and growth potential of this defensive industry.
Negative Factors
Geographic Concentration
The ETF is heavily concentrated in Switzerland, which limits diversification and increases exposure to country-specific risks.
Underperforming Holdings
Some holdings, such as Holcim and Lonza Group, have struggled with weak year-to-date performance, dragging on overall returns.
Sector Imbalance
The ETF is heavily weighted toward health care and consumer defensive sectors, which may limit exposure to faster-growing industries like technology.
FLSW vs. SPDR S&P 500 ETF (SPY)
AUM60.80M
RegionEurope
Expense Ratio0.09%
Beta0.54
IssuerFranklin
Inception DateFeb 06, 2018
Dividend Yield2.08%
Asset ClassEquity
Index TrackedFTSE Switzerland RIC Capped Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume4,739
30 Day Avg. Volume3,978
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
42.07Price Target Upside― Downside
Rating ConsensusHold
Number of Analyst Covering51
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
FLSW Summary
The Franklin FTSE Switzerland ETF (FLSW) is an investment fund that focuses on the Swiss stock market, tracking the FTSE Switzerland RIC Capped Index. It includes a mix of large, mid, and small companies across industries like healthcare, consumer goods, and financial services. Some well-known companies in this ETF are Nestlé and Roche. Investors might consider FLSW for diversification and exposure to Switzerland’s stable and innovative economy. However, new investors should note that the ETF’s performance is closely tied to the Swiss market, which can fluctuate based on local and global economic conditions.
How much will it cost me?The Franklin FTSE Switzerland ETF (FLSW) has an expense ratio of 0.09%, meaning you’ll pay $0.90 per year for every $1,000 invested. This is lower than average because it’s a passively managed fund that tracks an index, which typically involves lower costs compared to actively managed funds.
What would affect this ETF?The Franklin FTSE Switzerland ETF could benefit from Switzerland's stable economy and strong performance in sectors like healthcare and consumer defensive, which are less sensitive to economic downturns. However, challenges such as global economic slowdowns, regulatory changes in the pharmaceutical industry, or fluctuations in the financial sector could negatively impact its top holdings and overall performance.
FLSW Top 10 Holdings
The Franklin FTSE Switzerland ETF leans heavily on healthcare giants like Roche and Novartis, which have been steady performers, bolstered by strong pipelines and robust profitability. Nestlé, a consumer defensive stalwart, adds stability but has shown mixed momentum recently. Financial names like UBS and Zurich Insurance are dragging slightly, with sector-specific challenges weighing on their performance. With healthcare dominating the fund and consumer defensive and financials close behind, the ETF is firmly rooted in Switzerland’s economic backbone, offering a blend of innovation and resilience in a concentrated European market.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Roche Holding AG | 13.34% | $7.97M | CHF253.28B | 42.40% | 73 Outperform | |
| Nestlé SA | 11.84% | $7.07M | CHF197.01B | 16.44% | 71 Outperform | |
| Novartis AG | 11.83% | $7.06M | CHF200.79B | 20.24% | 80 Outperform | |
| UBS Group AG | 6.79% | $4.05M | $134.75B | 35.62% | 73 Outperform | |
| ABB Ltd | 5.74% | $3.43M | kr1.23T | 14.92% | 78 Outperform | |
| Compagnie Financiere Richemont SA | 4.70% | $2.81M | CHF97.61B | 22.05% | 78 Outperform | |
| Zurich Insurance Group | 4.38% | $2.62M | CHF82.76B | 14.81% | 78 Outperform | |
| Holcim | 2.70% | $1.61M | CHF40.70B | -16.18% | 73 Outperform | |
| Swiss Re AG | 2.62% | $1.57M | CHF35.33B | 9.31% | 73 Outperform | |
| Lonza Group Ltd | 2.60% | $1.55M | CHF35.17B | -3.38% | 71 Outperform |
FLSW Technical Analysis
Positive
―
Price Trends
39.41
Positive
38.75
Positive
37.59
Positive
Market Momentum
0.38
Negative
65.45
Neutral
62.19
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For FLSW, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 39.79, equal to the 50-day MA of 39.41, and equal to the 200-day MA of 37.59, indicating a bullish trend. The MACD of 0.38 indicates Negative momentum. The RSI at 65.45 is Neutral, neither overbought nor oversold. The STOCH value of 62.19 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FLSW.
FLSW Peer Comparison
Comparison Results
Performance Comparison
FLSW
Franklin FTSE Switzerland ETF
40.88
8.79
27.39%
EWL
iShares MSCI Switzerland ETF
―
―
―
FEUZ
First Trust Eurozone AlphaDEX ETF
―
―
―
EUDG
WisdomTree Europe Quality Dividend Growth Fund
―
―
―
FGM
First Trust Germany AlphaDEX Fund
―
―
―
FSZ
First Trust Switzerland AlphaDEX Fund
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents